Rationale: Epilepsy surgery is a standard of care in the treatment of medically intractable epilepsy, but is underutilised. We describe the results of epilepsy surgery and the referral patterns at a referral epilepsy programme. . Duration of seizures before being seen at the epilepsy centre averaged 18 years (range 2-58 years). Twenty-two (61%) were sent by their neurologists, while 14 (39%) came self-referred without having discussed surgery with their neurologists. Five (14%) were specifically advised by their neurologist to not consider surgery. Two had participated in clinical trials of antiepileptic drugs (AEDs) before being seen at the epilepsy centre. Conclusions: Epilepsy surgery has high efficacy and very low morbidity. Yet, there continues to be a long delay in the referral of patients to the epilepsy centre, suggesting that surgery for epilepsy is underutilised.
INTRODUCTION
Epilepsy is one of the commonest neurologic diseases, affecting 1% of the population. It is well established that 20-30% of patients with chronic seizures are not adequately controlled by medications [1] [2] [3] [4] , and that epilepsy surgery is standard of care 1, 3, 5 in this situation. However, surgery for epilepsy is underutilised and it is believed that physicians fail to refer patients or refer them too late 4 .
We herein describe the results of epilepsy surgery at a single referral epilepsy programme, and examine the referral patterns and time frames to determine how and when in the course of their illness patients arrive ଝ Presented in part at the 55th Annual Meeting of the American Epilepsy Society, December 5, 2001 , Philadelphia.
at a referral epilepsy centre and undergo surgery. We then discuss possible ways to improve accessibility of patients to epilepsy surgery.
METHODS
We reviewed the outcome of epilepsy surgery performed at our referral epilepsy programme (University of South Florida and Tampa General Hospital). We included all cases of epilepsy surgery operated on by a single (epilepsy) neurosurgeon (FLV) during a 2-year period (January 1, 2000 to December 31, 2001), not including vagus nerve stimulator (VNS).
The typical presurgical evaluation included clinical evaluation, EEG-video monitoring, MRI with dedicated epilepsy protocol, PET or SPECT scan, neuropsychological testing and Wada testing. A relatively standardised algorithm was generally followed 1 . We used the Engel outcome classification 6 .
RESULTS
In the 2-year period, a total of 36 epilepsy surgeries were performed: 29 temporal lobectomies, 6 extratemporal resections and 1 corpus callosotomy. Ages varied from 17 to 65 years. Of the 35 resections, 4 were preceded by invasive EEG (subdural in 3 and epidural in 1). 
Efficacy

Safety and complications
One intraoperative lacunar stroke occurred in a 65-year-old woman, which resulted in left upper extremity monoparesis. Interestingly, despite her new deficit, this patient felt she was better off after surgery, as she had a seizure-free outcome and no longer had to visit the emergency department on a regular basis. Two patients had a postoperative superficial infection that was successfully treated with antibiotics.
How do patients end up at the epilepsy centre?
Duration of seizures before being seen at the epilepsy centre averaged 18 years (range 2-58 years). Twenty-two (61%) were sent by their neurologists, while 14 (39%) came self-referred without having discussed surgery with their neurologists. Five (14%) were specifically advised by their neurologist to not consider surgery. Two patients had participated in clinical trials of antiepileptic drugs (AEDs) before being seen at the epilepsy centre.
DISCUSSION
As in other series, temporal lobectomies were by far the most common operation. Also similar to previous reports, outcome was excellent.
We found a long delay in the referral of patients to the epilepsy centre. This is comparable to a recent series of 89 temporal lobectomies, which reported a mean duration of epilepsy of 18.8 years prior to surgery despite a median seizure frequency of 8 per month 7 . In that study, some of the delay may have been related to the presurgical evaluation, whereas we measured the delay to the first visit at the epilepsy centre (epileptologist). Another important and related finding was that a significant proportion (39%) of patients were not sent by their neurologists and had not been given an opportunity to discuss this option. In fact some (14%) were specifically advised against surgery and given dissuasive information about epilepsy surgery, especially about serious neurologic complications. This has not been previously reported, but is critical, since it likely results in many surgical candidates never accessing an epilepsy centre and is likely an important cause for the underutilisation of epilepsy surgery.
The reasons for this poor referral patterns are unclear and probably diverse. One possible cause is lack of familiarity (of neurologists) with the efficacy and low morbidity of epilepsy surgery. As a result, they may have misconceptions and convey lack of efficacy or, more often, risk of severe postoperative deficits, as was the case for several of our patients. Yet, there is abundant literature available, including entire textbooks dedicated to the topic of epilepsy surgery 8, 9 . There are even published (but little known) guidelines on the time frames for referring patients to an epilepsy centre, which state that referral to a specialised epilepsy centre is appropriate if seizure control is not achieved within 9 months by the general neurologist 10, 11 .
Another problem is defining intractability, or how many drugs should be tried before declaring a patient medically intractable, which remains an individual and variable decision. Nevertheless, it is now known that the chances of seizure control decline rapidly after the first few AED trials. Whether with classic AEDs 12 , or newer generation AEDs 13 , only 9-14% of patients eventually become controlled with drugs after the first one fails. This in fact is even largely true in children 14 . An increasingly used definition of medical intractability, at least in adults, is persistent seizures despite 2 years and two maximally tolerated AED trials 12, 15 . In this situation, nonpharmacologic options should be examined early rather than as a last resort 1, 3, 4, 7, 13 . A recently published expert-opinion consensus on the treatment of epilepsy was also in agreement with this 16 . A relatively common situation is that acceptable seizure control is obtained at the expense of severe side effects that impair quality of life (e.g. patients report extreme fatigue, clouded thinking, dizziness, etc.). This in fact constitutes drug failure, but this concept is often overlooked, and patients are often taught that no alternatives exist outside of 'more medications'.
Another possible explanation is that general neurologists are not equipped to identify potential surgical candidates. However, the fact that our outcome was excellent and comparable to other large series 2, 7 indicate that these patients did not present any unusual difficulties in order to be identified as potential surgical candidates. In fact, most had straightforward mesial temporal sclerosis, which should be relatively easy to identify on clinical grounds 4, 17 .
Finally, a more concerning possible reason may be the desire for physicians to 'keep their patients' for a variety of reasons, including to enroll some in industry-sponsored clinical trials.
The consequences of years of ongoing seizures are well known, and include severe psychosocial consequences 4, 18 that may not resolve if seizure-free status is achieved too late. Postoperative outcome also appears to be adversely affected by a longer duration of chronic seizures 19 . In addition, mesial temporal lobe epilepsy may well be a progressive disorder 4 , and is particularly likely to become intractable 20 . Finally, it has been argued that the risk of death from ongoing seizures is higher than that from a typical temporal lobectomy 4, 7, 21 .
Whatever the reasons for this poor referral pattern, epilepsy surgery is standard of care when medications fail, and thus it can be argued that not referring patients with intractable seizures to the epilepsy centre may raise issues of ethics. Failing to offer the possibility of (and evaluation for) nonpharmacologic treatments (i.e. surgery, VNS, or ketogenic diet) amounts to withholding information, and as such violates the principle of autonomy (letting patients decide if they are interested in these options). It also violates the principle of beneficence (providing the best available treatment). Specifically, we believe that it is certainly unethical to enroll patients for investigational treatments (e.g. drug studies) before at least offering an evaluation at a comprehensive (surgical) epilepsy centre. Several patients in this series clearly stated that they were never offered nonpharmacologic options, and two were enrolled in a drug study.
We believe that this is a serious problem. Epilepsy is one area of neurology where patients can actually be cured and have their lives radically changed. Perhaps general neurologists believe that these patients are rare. Based on the epidemiology (prevalence of 1%) and natural history (20% intractable) of epilepsy, there are probably as many potential surgical candidates as patients with multiple sclerosis! Thus, every general neurology practice likely sees these patients, and one that never refers to the epilepsy centre is in all likelihood failing to identify them. A recent randomised trial of surgery in patients with poorly controlled temporal lobe epilepsy 21 strongly argues for the superiority of surgery over medical therapy in terms of seizure control, quality of life, rates of employment and school attendance. Another upcoming randomised controlled US trial may help further 4 , and many patients could certainly testify that their lives have been changed 22 . Education about epilepsy surgery is seriously needed, both to the public and to health care professionals, and including neurologists, as epilepsy surgery continues to be underutilised. As mentioned earlier, the only guidelines for referral to epilepsy centres were published in a subspecialty journal 10, 11 . Such guidelines should be more widely published (e.g. by the AAN) in order to be available to the general neurologist, and specific emphasis should be placed on when and whom to refer to the epilepsy centre.
